FLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signaling (Q28591863)

31 January 2017

title

FLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signaling (English)

1 reference

TRAF type zinc finger domain containing 1

31 January 2017

0 references

1 reference

TNF receptor-associated factor 6

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

Hiroyuki Aburatani

1 reference

31 January 2017

Ryuichi Mashima

1 reference

31 January 2017

Kazuko Saeki

1 reference

31 January 2017

Daisuke Aki

1 reference

31 January 2017

Yasumasa Minoda

1 reference

31 January 2017

Hiromi Takaki

1 reference

31 January 2017

Takahito Sanada

1 reference

31 January 2017

Takashi Kobayashi

1 reference

31 January 2017

Yuji Yamanashi

1 reference

31 January 2017

Akihiko Yoshimura

1 reference

31 January 2017

language of work or name

English

0 references

publication date

16 December 2005

1 reference

Journal of Biological Chemistry

31 January 2017

published in

1 reference

31 January 2017

volume

280

1 reference

31 January 2017

1 reference

31 January 2017

page(s)

41289–41297

1 reference

Innate immune recognition

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

Toll-like receptors: critical proteins linking innate and acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

MyD88: An Adapter That Recruits IRAK to the IL-1 Receptor Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

MyD88, an adapter protein involved in interleukin-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

Distinct molecular mechanism for initiating TRAF6 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

Mechanisms of endotoxin tolerance. IV. Specificity of the pyrogenic refractory state during continuous intravenous infusions of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

IRAK-M is a negative regulator of Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

The B cell-specific major raft protein, Raftlin, is necessary for the integrity of lipid raft and BCR signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3...

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

Low responsiveness to IFN-gamma, after pretreatment of mouse macrophages with lipopolysaccharides, develops via diverse regulatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508221200

21 January 2018

Identifiers

DOI

10.1074/JBC.M508221200

1 reference

31 January 2017

1 reference